Researchers have received funding to screen and evaluate adjuvants that may improve the ability of coronavirus vaccines to simulate the immune system.
Krishnendu Roy and Johnna Temenoff lead a NSF Engineering Research Center at Tech
Linda Ho, a master's student in the School of Public Policy, has crafted an educational experience with elements of both science and policy studies.
Georgia Tech and CMaT host ASTM International workshop focused on cell and tissue manufacturing
NSF Cell Manufacturing Technologies Center gathering in Athens for annual retreat
CMaT collaborates with Georgia Bio to create new training program for rural Georgia
Steve Stice: Using Living Cells to Change the Course of Disease
Grad students from Georgia Tech and three other universities get rare close-up look at big pharma facility
Marcus Center leading three-year collaborative effort with GTRI, ISyE and Duke University
Researchers have demonstrated an integrated technique for monitoring specific biomolecules.
In The News
National Institutes of Health funds Georgia Tech researchers to evaluate specific molecules that may help the development of a COVID-19 vaccine
NSF grant to fund study of factors that help underrepresented students
Sponsored by BioProcess International and its sister publication BioProcess Insider, the “Tech of Tomorrow Zone” at Phacilitate 2020 played host to a number of companies showcasing platforms and ideas that they believe can revolutionize cell and gene ther
Included in Georgia’s 2020 budget signed into law by Governor Brian Kemp on May 10 are funds to support life sciences education in rural school systems through the Georgia Department of Education and the Georgia Youth Science & Technology Centers.
When manipulating the functions of cells, researchers need to take a multidisciplinary approach.
Randolph Ashton, assistant professor of biomedical engineering, is the new associate director for UW–Madison’s Stem Cell and Regenerative Medicine Center.
UW-Madison’s Forward BIO Institute has been awarded $5 million from the National Institutes of Health for tissue manufacturing.
Officials with UW-Madison, the biohealth industry and the state’s economic development agency announced the launch of a new biomanufacturing initiative Thursday to enhance opportunities for Wisconsin researchers and entrepreneurs.
Researchers have demonstrated an integrated technique for monitoring specific biomolecules -- such as growth factors -- that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics.
Dr. Carl June, introduced as “the cancer slayer” at an immunotherapy conference here, challenged scientists to be far more aggressive about pushing their perspectives in the White House and Congress.